Navigation Links
Start-up Seeks Crowd Funding to Complete Clinical Studies Supporting Breakthrough Blood Test for Earlier Detection of Melanoma
Date:8/13/2013

LOUISVILLE, Ky., Aug. 13, 2013 /PRNewswire-iReach/ -- In collaboration with the James Graham Brown Cancer Center at the University of Louisville, LBIdx™ is advancing a breakthrough blood test, the Plasma Thermogram™ (pT). Based on a simple blood draw, researchers at LBIdx™ and the Brown Cancer Center see great promise for the pTtest as a "game-changer" allowing physicians to monitor cancer patients more closely. Monitoring is a critical part of cancer treatment and provides physicians with vital information in the fight against cancer.

LBIdx™ and the Brown Cancer Center are initiating a clinical study that will demonstrate the pT test's capabilities for improved monitoring of melanoma patients at dangerous risk of metastasis and for response to medical treatment. Director Donald Miller M.D., Ph.D. and Deputy Director Jason A. Chesney, M.D., Ph.D., will be co-investigators of the planned study to detect earlier signs of change in disease status. Researchers expect the pTwill provide a unique insight into cancer status leading to improved medical response options, including therapy. Equally important, this test stands to be an earlier indicator or remission or relapse.  In all, the test stands to help answer those age-old questions, "Am I winning my battle with cancer?" and "Is my cancer gone?" 

Current medical practice frequently relies on medical imaging procedures, like CT scans, to monitor melanoma patients. But due to the high dose radiation exposure from each procedure, their use by physicians is limited, which can hinder patient monitoring.  In addition, the FDA is striving to reduce unnecessary radiation exposure from these medical imaging procedures which are the greatest contributors to total radiation exposure within the U.S.

Alfred "Ben" Jenson, Professor of Vaccinology at the James Graham Brown Cancer Center and co-inventor of the pThas been a strong supporter of the pT's cancer monitoring potential.  Ben is also known for his work as co-inventor of the cervical cancer vaccine, Gardasil, and sees potential for the pT as a monitoring tool for a multitude of cancers, including difficult-to-detect oral cancers.

LBIdx™ is a start-up company, focused on the commercialization of pT tests for cancer monitoring and prognosis. It is currently raising funds via a crowd funding campaign allowing the public, who will benefit from such a test, to support this enhanced cancer monitoring effort. Crowd funding is a relatively new concept approved by the U.S. Jobs Act of 2012. Details of their 'Breakthrough in Cancer Detection & Monitoring' campaign can be found on the Indiegogo crowd funding website using the following link, http://igg.me/at/CancerDetectionStudy.

About Louisville Bioscience, Inc.

LBIdx™, headquartered in Louisville, Kentucky, is a start-up company with an exclusive license to the University of Louisville Plasma Thermogram™ (pT) technology and focused on the commercialization of pT tests for cancer monitoring and prognosis.  The novel pT blood test can provide earlier detection of disease, effectively assess status of cancer remission and improve monitoring in response to therapy for numerous cancers including: melanoma, breast, cervical, ovarian and lung cancers. The pT diagnostic platform utilizes Differential Scanning Calorimetry (DSC) to generate a robust temperature-induced melting profile of the major blood proteins. The LBIdx™ core technology was invented by the University of Louisville team of Dr. Jonathan Chaires (James Graham Brown Endowed Chair of Cancer Biophysics), Dr. Nichola Garbett and Dr. Alfred "Ben" Jenson. For more information, please visit www.lbidx.com

Media Contact: Michael Birdsell, LBIdx, 502.414.1243, mbirdsell@lbidx.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE LBIdx
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Cloud-Based Investigator Portal from Veeva Systems Speeds Clinical Study Start-Up
2. Structure-Based Drug Design Conference in Boston, Starting June 19 PLUS These 62 Start-ups and Small Companies Will Transform Drug Delivery Technology
3. Janssen Labs at San Diego Expands to Add Concept Lab and Open Collaboration Space to Accommodate Individual Entrepreneurs and Additional Life Science Start-Ups
4. Foundation Venture Capital Group Invests In Start-Up Working to Reduce Side Effects of Parkinsons Treatment
5. Helping Start-Ups Avoid Slow-Downs
6. Fuisz Pharma Announces Intent to Divest Strategic Patent for Detection of Opioid Abuse; Seeks Offers for Patent through May 2013
7. $1,000,000 Global B.R.A.I.N. Prize Seeks Applicants
8. American Academy of Pain Medicine Reacts to PROP Petition to the FDA that Seeks to Limit Pain Medications for Legitimate Noncancer Pain Sufferers
9. Searcy Denney Scarola Barnhart & Shipley PA Seeks Damages Caused by Recalled Product
10. Separation Design Group Launches Crowd-Funding Campaign for Worlds Smallest Oxygen Machine
11. Prosum Kicks Off Crowd Funding for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Corporate Whistleblower Center is urging a physician ... 866-714-6466 if they possess proof a pharmaceutical company is bribing doctors ... the innocent patients frequently being the victims, these types of schemes ... Medicare recipients or the elderly. Photo ... ...
(Date:12/7/2016)... , Dec. 7, 2016   Rx Savings Solutions ... and its Public Employees Insurance Agency (PEIA) to ... to their innovative healthcare software, ultimately saving money on their ... and provide its members with access to our software that ... more effective, affordable therapy can be found," says Michael ...
(Date:12/7/2016)... 2016  Varian Medical Systems (NYSE: VAR ... plans to separate its Imaging Components business.  The separation ... to Varian stockholders of common stock in Varex Imaging ... the Imaging Components business.  As part of the separation, ... end of January 2017, Varian will receive an approximate ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... Augustine Insurance Agency, a ... and business owners in the greater Dallas metropolitan area, is announcing a charity ... Foundation. , Established in 2009 by active police professionals in the Dallas region, ...
(Date:12/7/2016)... ... ... A. Kevin Spann Insurance, a New York-based firm offering insurance and financial ... charity drive to raise funds that will benefit the Marine Corps League. , The ... FMF Corpsmen. Working closely with the MCL, the A. Kevin Spann team plans to ...
(Date:12/7/2016)... ... December 07, 2016 , ... The ... its fully redesigned website, which launched October 17, 2016, features comprehensive information regarding ... and easy-to-navigate layout. Visitors and patients can discover the latest clinical dermatology treatments ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... Texas, is condemning "scam operations" carried out by unethical locksmith companies and is ... operations to a halt. According to Texas Premier Locksmith, these fraudulent locksmith services ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... "ProBrand Flip ... and all media," said Christina Austin - CEO of Pixel Film Studios. , ProBrand ... easy to use drop zones. Editors can select from a variety of flip book ...
Breaking Medicine News(10 mins):